Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis

Etiology, Management, and Outcome of the Budd-Chiari Syndrome

(2013) Sarwa Darwish Murad   ANNALS OF INTERNAL MEDICINE

JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis: authors’ reply

(2011) R. H. Westbrook et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis

(2011) X. Qi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prevalence of the JAK2 V617F and MPL Mutations in Stroke, Abdominal and Peripheral Venous Thrombosis

(2010) Niamh McCarthy et al.   ACTA HAEMATOLOGICA

The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis

(2010) D. W. ORR et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

JAK2Mutations Across a Spectrum of Venous Thrombosis Cases: Table 1

(2010) Shrimati Shetty et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Splanchnic vein thrombosis: clinical presentation, risk factors and treatment

(2010) Valerio De Stefano et al.   Internal and Emergency Medicine

Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis

(2010) Srdan Verstovsek et al.   NEW ENGLAND JOURNAL OF MEDICINE

JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis

(2009) F. Dentali et al.   BLOOD

Occurrence of the JAK2 V617F mutation in the Budd–Chiari syndrome

(2009) Donatella Colaizzo et al.   BLOOD COAGULATION & FIBRINOLYSIS

JAK2V617F Mutation in Patients with Splanchnic Vein Thrombosis

(2009) Sandra Guerra Xavier et al.   DIGESTIVE DISEASES AND SCIENCES

Janus kinase-2 mutation, cirrhosis and splanchnic vein thrombosis

(2009) Donatella Colaizzo et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study

(2009) Aurelie Plessier et al.   HEPATOLOGY

Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development

(2009) Maria Assunta Zocco et al.   JOURNAL OF HEPATOLOGY

ClinicalJAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations

(2008) Gregory A. Abel et al.   AMERICAN JOURNAL OF HEMATOLOGY

JAK2V617F: better diagnostic tool than marrow?

(2008) H. C. Kwaan   BLOOD

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

(2008) J.-J. Kiladjian et al.   BLOOD

JAK2V617F Mutation in Patients with Portal Vein Thrombosis

(2008) Yusuf Bayraktar et al.   DIGESTIVE DISEASES AND SCIENCES

Primary thrombophilia in México VII: the V617F mutation ofJAK2is not a frequent cause of thrombosis

(2008) Javier Garcés-Eisele et al.   Hematology

Vascular disorders of the liver

(2008) Laurie D. DeLeve et al.   HEPATOLOGY

JAK2 V617F mutation is not involved in thromboembolism in IBD

(2008) Ouafae Karimi et al.   INFLAMMATORY BOWEL DISEASES

TheJAK2V617Ftyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis

(2007) C. GOULDING et al.   International Journal of Laboratory Hematology